Department of Preventive Medicine Institute for Prevention Research Keck School of Medicine
1000 S. Fremont Ave., Unit 8 HSA Bldg. A-4, RM 4113, MC 0000
Alhambra, CA
USA 91803
Email: rbluthen@usc.edu
Disclosure statement:
Qualified on the content I am responsible for because: I have conducted studies on and written extensively in the area of HIV prevention for injection drug users. In particular, I have conducted studies on the impacts of policies on HIV prevention for this population (see list below). The studies in this session add to this previous work by documenting public health advances related to non-prescription, over-the-counter sales of syringes.
Selected list of relevant publications:
1) Bluthenthal RN, Heinzerling KG, Flynn NM, Anderson R, Kral AH. Approval of syringe exchange programs in California: Mixed results from a local approach to HIV prevention. American Journal of Public Health. 2008; 98(2):278-83.
2)5. Bluthenthal RN. Syringe exchange as a social movement: A case study of harm reduction in Oakland, California. Substance Use & Misuse. 1998;33(5):1146-1171.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.